pharmaceutical

Kodak Loan Involved No Wrongdoing, DFC Concludes
Risk & Compliance

Kodak Loan Involved No Wrongdoing, DFC Concludes

The company was cleared to receive a $765 million federal loan to make drug ingredients for the U.S. government.
By Lauren Muskett | December 7, 2020
Read More
Amazon Opens Online Pharmacy
Tech

Amazon Opens Online Pharmacy

“The news represents a disruption to the system and competitive threat that will likely shift scripts away from the retail channel.”
By Lauren Muskett | November 17, 2020
Read More
Trump Administration Unveils Deal to Make COVID-19 Drugs in U.S.
Risk & Compliance

Trump Administration Unveils Deal to Make COVID-19 Drugs in U.S.

The $354 million project is designed to reduce the country's reliance on drugs and pharmaceutical ingredients from foreign manufacturers.
By Lauren Muskett | May 19, 2020
Read More
Eli Lilly to Buy Cancer Drug Specialists Loxo Oncology
M&A

Eli Lilly to Buy Cancer Drug Specialists Loxo Oncology

In the second major pharmaceutical deal of the year, Eli Lilly will pay about $8 billion for Loxo Oncology.
By William Sprouse | January 7, 2019
Read More
Bristol-Myers to Buy Big Pharma Rival Celgene
M&A

Bristol-Myers to Buy Big Pharma Rival Celgene

The $74 billion deal could create the fourth-largest U.S. pharma firm, with a portfolio that includes nine blockbuster drugs.
By Matthew Heller | January 3, 2019
Read More
New Products Fuel Eli Lilly Q1 Earnings Beat
Financial Performance

New Products Fuel Eli Lilly Q1 Earnings Beat

Drugs such as the diabetes treatment Trulicity "led the company to a strong quarter of volume-driven revenue growth."
By Matthew Heller | April 26, 2017
Read More
Bayer Discloses $62B Offer for Monsanto
Strategy

Bayer Discloses $62B Offer for Monsanto

The deal would create the world's largest agricultural supplier but Bayer shareholders fear it will be detrimental to its pharmaceutical business
By Katie Kuehner-Hebert | May 23, 2016
Read More
Mylan to Pay 92% Premium for Sweden’s Meda
Risk

Mylan to Pay 92% Premium for Sweden’s Meda

After a relentless pursuit, pharmaceutical firm Mylan pays a large premium to acquire a company that sells over-the-counter drugs.
By Matthew Heller | February 11, 2016
Read More
Pfizer Buys Allergan for $160B
Tax

Pfizer Buys Allergan for $160B

The companies predict the combined entity would have more than $25 billion in operating cash flow starting in 2018.
By Katie Kuehner-Hebert | November 23, 2015
Read More